Skip to main content

Client News

Apogenix to Present New Data on Asunercept at ESMO Immuno-Oncology Congress

5th December 2019

InfanDx completes enrollment for BANON study evaluating its diagnostic HypoxE-test® for newborn asphyxia

3rd December 2019

ADL Bionatur Solutions Wins New Fermentation Client With Contract Revenues of EUR 20 Million

2nd December 2019

Ergomed plc: Lewis Cameron, Former Head of Global Clinical Development at Covance, Appointed as Chief Operating Officer

2nd December 2019

ViGeneron announces closing of series A financing to drive development of next generation gene

28th November 2019

Proteros, co-founder of Rodin Therapeutics, announces Rodin’s acquisition by Alkermes

28th November 2019

Vivoryon Therapeutics Reports Third Quarter 2019

28th November 2019

American Depositary Shares (“ADS”) Program and Warrant Agent Agreement

27th November 2019

Motif Bio plc Announces Voluntary Delisting from the Nasdaq Capital Market

26th November 2019

Newron Receives Second Tranche from Financing Agreement with European Investment Bank (EIB)

25th November 2019